OR WAIT null SECS
December 14, 2023
Bill Trombetta, PhD, discusses successfully navigating what he calls “the coming perfect storm” in healthcare.
December 12, 2023
Bayer executive talks Enable Holistic Hub and Provider Services panel.
Session discusses ways to integrate digital pharmacies and hubs.
Founding Partner of Curatio Scientia speaks on her upcoming panel at Trade & Channel Strategies 2023.
December 11, 2023
Lexicon Pharmaceuticals exec discusses upcoming Enable Holistic Hub and Provider Services panel.
Panel uncovers ways to handle the increasing complexities and risks surrounding commercialization.
Conference keynote offers an industry outlook, including new commercialization challenges.
Adults and children aged 1 year and older are eligible for the IV formulation of Cresemba for invasive aspergillosis and invasive mucormycotic, whereas the prescribed capsule is only indicated for adults and children 6 years of age and older.
December 07, 2023
An independent Data Monitoring Committee found that Keytruda in combination with chemotherapy followed by Keytruda plus Lynparza did not produce an improved overall survival benefit vs. Keytruda in combination with chemotherapy followed by Keytruda plus a placebo in patients with metastatic squamous non-small cell lung cancer.
November 10, 2023
Financial commitment further strengthens IntegriChain’s platform as a source for pharma manufacturers' commercialization and market access goals.